Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation

PHASE4TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2009

Conditions
Atherosclerotic Cardiovascular Disease
Interventions
DRUG

L-arginine + heme arginate

L-arginine first, heme arginate second three day treatment

DRUG

Heme arginate + L-arginine

Heme arginate first, L-arginine second three day treatment

Trial Locations (1)

Unknown

Radboud University Nijmegen Medical Centre, Nijmegen

Sponsors
All Listed Sponsors
collaborator

Dutch Diabetes Research Foundation

OTHER

lead

Radboud University Medical Center

OTHER